Reverse Phase Protein Arrays for High-throughput Toxicity Screening

Marlene Lemvig Pedersen, Ines Block, Markus List, Helle Christiansen, Steffen Schmidt, Jan Mollenhauer

    Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review


    High-throughput screening is extensively applied for identification of drug targets and drug discovery and recently it found entry into toxicity testing. Reverse phase protein arrays (RPPAs) are used widespread for quantification of protein markers. We reasoned that RPPAs also can be utilized beneficially in automated high-throughput toxicity testing. An advantage of using RPPAs is that, in addition to the baseline toxicity readout, they allow testing of multiple markers of toxicity, such as inflammatory responses, which do not necessarily cumulate in cell death. We used transfection of siRNAs with known killing effects as a model system to demonstrate that RPPA-based protein quantification can serve as substitute readout of cell viability, hereby reliably reflecting toxicity. In terms of automation, cell exposure, protein harvest, serial dilution and sample reformatting were performed using a robotic screening platform. Furthermore, we automated sample tracking and data analysis by developing a bundled bioinformatics tool named “MIRACLE”.
    Automation and RPPA-based viability/toxicity readouts enable rapid testing of large sample numbers, while granting the possibility for flexible consecutive quantification of additional user-defined toxicity markers.
    Publikationsdato12. okt. 2015
    StatusUdgivet - 12. okt. 2015
    Begivenhed5th Global Reverse Phase Protein Array Workshop - George Mason University, Manassas, Virginia, USA
    Varighed: 12. okt. 201513. okt. 2015


    Konference5th Global Reverse Phase Protein Array Workshop
    LokationGeorge Mason University
    ByManassas, Virginia


    Dyk ned i forskningsemnerne om 'Reverse Phase Protein Arrays for High-throughput Toxicity Screening'. Sammen danner de et unikt fingeraftryk.